Citations

Showing 10 of 108104 citations.

Development and Assessment of a Method to Estimate the Value of a Maximum Voluntary Isometric Contraction Electromyogram from Submaximal Electromyographic Data
Koenig, Jordyn , Mirka, Gary A. , Norasi, Hamid

Mayo Clinic

Journal of Applied Biomechanics | February 25, 2022 | Volume: 38 | Issue: 2 | Pages: 76-83

10.1123/jab.2021-0229 | PMID 35213822 Get It

The electromyographic (EMG) normalization (often to maximum voluntary isometric contraction [MVIC]) is used to control for interparticipant and day-to-day variations. Repeated MVIC exertions may be inadvisable from participants’ safety perspective. This study developed a technique to predict the MVIC EMG from submaximal isometric voluntary contraction EMG. On day 1, 10 participants executed moment exertions of 100%, 60%, 40%, and 20% of the maximum (biceps brachii, rectus femoris, neck flexors, and neck extensors) as the EMG data were collected. On day 2, the participants replicated the joint moment values from day 1 (60%, 40%, and 20%) and also performed MVIC exertions. Using the ratios between the MVIC EMGs and submaximal isometric voluntary contraction EMG data values established on day 1, and the day 2 submaximal isometric voluntary contraction EMG data values, the day 2 MVIC EMGs were predicted. The average absolute percentage error between the predicted and actual MVIC EMG values for day 2 were calculated: biceps brachii, 45%; rectus femoris, 27%; right and left neck flexors, 27% and 33%, respectively; and right and left neck extensors, both 29%. There will be a trade-off between the required accuracy of the MVIC EMG and the risk of injury due to exerting actual MVIC. Thus, using the developed predictive technique may depend on the study circumstances.
Experiences of Discrimination, Institutional Responses to Seminal Race Events, and Depressive Symptoms in Black U.S. Medical Students
Milam, Adam J. , Brown, Italo M. , Edwards-Johnson, Jennifer, Sousa, Aron, Furr-Holden, Debra, Milam, Adam J , McDougle, Leon , Furr-Holden, Debra

Mayo Clinic

Academic Medicine | February 25, 2022 | Volume: 97 | Issue: 6 | Pages: 876-883

10.1097/acm.0000000000004638 | PMID 35703911 Get It

Purpose To examine the relationship between experiences of discrimination, institutional responses to seminal race events, and depressive symptoms among Black medical students. Method This study collected data from a convenience sample of Black U.S. medical students via an anonymous electronic questionnaire in August 2020 that was distributed through the Student National Medical Association and Organization of Student Representatives listservs and an author’s social media accounts. It included questions on demographics, institutional responses to seminal race events, experiences of discrimination, and symptoms of depression. Path models were used to examine the relationship between experiences of discrimination, institutional responses to seminal race events, and depressive symptoms among Black medical students. Results Of the 750 students completing the survey, 733 (97.7%) were Black. Experiences of discrimination and a lack of institutional responses to seminal race events were associated with more depressive symptoms ( b = 0.19, 95% CI: 0.11, 0.26; P < .001 and b = 0.12, 95% CI: 0.04, 0.20; P = .01). After controlling for gender and clinical diagnosis of depression or anxiety before medical school, there was a relationship between experiences of discrimination and institutional responses to seminal race events such that students who reported more experiences of discrimination were more likely to report that their institution did not respond to seminal race events ( b = 0.41, 95% CI: 0.34, 0.48; P < .001). Experiences of discrimination moderated the relationship between institutional responses to seminal race events and depressive symptoms (i.e., the relationship between a lack of institutional responses to seminal race events and depressive symptoms was stronger among students who reported more frequent experiences of discrimination). Conclusions Institutions dedicated to supporting Black medical student wellness must be diligent in cultivating a culture intolerant of discrimination and deft in their responses to seminal race events in the larger culture.
Six Principles for Developing Leadership Training Ecosystems in Health Care
Chen, Ruth , Lal, Sarrah , Chan, Teresa M. , Winters, Richard C.

Mayo Clinic

Academic Medicine | February 25, 2022 | Volume: 97 | Issue: 6 | Pages: 793-796

10.1097/acm.0000000000004640 | PMID 35703908 Get It

Leadership education in medicine is evolving to better meet the challenges of health care complexity, interprofessional practice, and threats from viruses and budget cuts alike. In this commentary, the authors build upon the findings of a scoping review by Matsas and colleagues, published in the same issue, and ask us to imagine what a learning ecosystem around leadership might look like. They subsequently engage in their own synthesis of leadership development literature and propose 6 key principles for medical educators and health care leaders to consider when designing leadership development within their educational ecosystems: (1) apply a conceptual framework; (2) scaffold development-oriented approaches; (3) accommodate individual levels of adult development; (4) integrate diversity of perspective; (5) interweave theory, practice, and reflection; and (6) recognize the broad range of leadership conceptualization.
Integration of mental health and supportive care in individuals with schizophrenia and cancer: Assertive community treatment model
Taylor-Desir, Monica , Sawchuk, Craig N. , Crane, Sarah J. , Carroll, Jamie L., Evans, Whitney S., Bogucki, Olivia E. , Taylor-Desir, Monica J., Carroll, Jamie M. , Lewis, Susan E. , Lapid, Maria I.

Mayo Clinic

Psycho-Oncology | February 25, 2022 | Volume: 32 | Issue: 7 | Pages: 1142-1144

10.1002/pon.5911 | PMID 35212429 Get It

Key points Persons with severe and persistent mental illness (SPMI) experience disparities in accessing and initiating cancer treatment The assertive community treatment (ACT) model promotes the integration of physical and mental health care and improves the quality of life for a patient diagnosed with cancer The ACT model is essential in promoting decisional capacity of those with SPMI and cancer diagnoses The ability to access 24‐h support from the ACT model provides psychological support to patients dealing with chronic physical health diagnoses Collaboration between cancer treatment teams and the multidisciplinary ACT team can improve treatment engagement and enhance a patient's natural support system
Cardiac ablation with pulsed electric fields: principles and biophysics
Sugrue, Alan , Munoz, Freddy Del‐Carpio , Killu, Ammar M. , Asirvatham, Samuel J. , Del-Carpio Munoz, Freddy , Asirvatham, Samuel J , Maor, Elad

Mayo Clinic

EP Europace | February 25, 2022 | Volume: 24 | Issue: 8 | Pages: 1213-1222

10.1093/europace/euac033 | PMID 35426908 Get It

Abstract Pulsed electric fields (PEFs) have emerged as an ideal cardiac ablation modality. At present numerous clinical trials in humans are exploring PEF as an ablation strategy for both atrial and ventricular arrhythmias, with early data showing significant promise. As this is a relatively new technology there is limited understanding of its principles and biophysics. Importantly, PEF biophysics and principles are starkly different to current energy modalities (radiofrequency and cryoballoon). Given the relatively novel nature of PEFs, this review aims to provide an understanding of the principles and biophysics of PEF ablation. The goal is to enhance academic research and ultimately enable optimization of ablation parameters to maximize procedure success and minimize risk.
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease
Bae, Kyongtae T., Tao, Cheng, Feldman, Robert, Yu, Alan S.L. , Torres, Vicente E., Perrone, Ronald D. , Chapman, Arlene B., Brosnahan, Godela, Steinman, Theodore I., Braun, William E., Mrug, Michal, Bennett, William M., Harris, Peter C., Srivastava, Avantika, Landsittel, Douglas P., Abebe, Kaleab Z., Harris, Peter C. , Torres, Vicente E. , Harris, Peter C , Torres, Vicente E , Yu, Alan S L , Torres, Vicente E , Bae, Kyongtae T., Tao, Cheng, Feldman, Robert, Torres, Vicente E., Chapman, Arlene B., Brosnahan, Godela, Steinman, Theodore I., Braun, William E., Mrug, Michal, Bennett, William M., Harris, Peter C., Srivastava, Avantika, Landsittel, Douglas P., Abebe, Kaleab Z.

Mayo Clinic

Clinical Journal of the American Society of Nephrology | February 25, 2022 | Volume: 17 | Issue: 3 | Pages: 374-384

10.2215/cjn.08660621 | PMID 35217526 Get It

Background and objectives The progression of polycystic liver disease is not well understood. The purpose of the study is to evaluate the associations of polycystic liver progression with other disease progression variables and classify liver progression on the basis of patient's age, height-adjusted liver cystic volume, and height-adjusted liver volume. Design, setting, participants, & measurements Prospective longitudinal magnetic resonance images from 670 patients with early autosomal dominant polycystic kidney disease for up to 14 years of follow-up were evaluated to measure height-adjusted liver cystic volume and height-adjusted liver volume. Among them, 245 patients with liver cyst volume >50 ml at baseline were included in the longitudinal analysis. Linear mixed models on log-transformed height-adjusted liver cystic volume and height-adjusted liver volume were fitted to approximate mean annual rate of change for each outcome. The association of sex, body mass index, genotype, baseline height-adjusted total kidney volume, and Mayo imaging class was assessed. We calculated height-adjusted liver cystic volume ranges for each specific age and divided them into five classes on the basis of annual percentage increase in height-adjusted liver cystic volume. Results The mean annual growth rate of height-adjusted liver cystic volume was 12% (95% confidence interval, 11.1% to 13.1%; P <0.001), whereas that for height-adjusted liver volume was 2% (95% confidence interval, 1.9% to 2.6%; P <0.001). Women had higher baseline height-adjusted liver cystic volume than men, but men had higher height-adjusted liver cystic volume growth rate than women by 2% (95% confidence interval, 0.4% to 4.5%; P =0.02). Whereas the height-adjusted liver cystic volume growth rate decreased in women after menopause, no decrease was observed in men at any age. Body mass index, genotype, and baseline height-adjusted total kidney volume were not associated with the growth rate of height-adjusted liver cystic volume or height-adjusted liver volume. According to the height-adjusted liver cystic volume growth rate, patients were classified into five classes (number of women, men in each class): A (24, six); B (44, 13); C (43, 48); D (28, 17); and E (13, nine). Conclusions Compared with height-adjusted liver volume, the use of height-adjusted liver cystic volume showed greater separations in volumetric progression of polycystic liver disease. Similar to the Mayo imaging classification for the kidney, the progression of polycystic liver disease may be categorized on the basis of patient’s age and height-adjusted liver cystic volume.
Polarization of Macrophages in Granulomatous Cutaneous T Cell Lymphoma Granulomatous Mycosis Fungoides Microenvironment
Johanny, Lopez Dominguez, Hobbs, Misty M. , Jiang, Liuyan , Sokumbi, Olayemi

Mayo Clinic

Dermatopathology | February 25, 2022 | Volume: 9 | Issue: 1 | Pages: 54-59

10.3390/dermatopathology9010009 | PMID 35323202 Get It

Polarization of tumor associated macrophages (TAMs) has been shown to have prognostic significance in different cancer types. This study evaluates the macrophage subtypes that predominates in GMF. Cases of GCTCL from 2007–2020 were identified (n = 6), clinical data was extracted from the electronic medical record, and all pathology slides were reviewed to confirm the diagnosis. Immunohistochemistry (IHC) studies were performed to characterize M1 and M2 macrophage polarization. CD68 (PGM1), pSTAT1, and CD163 were used as pan macrophage, M1, and M2 markers, respectively. The macrophages with positive staining at hot spot per high power field were counted and recorded for data analysis. The average age of patients was 60.5 years [range, 21–78], five patients (83%) were women and 1 (17%) was a man. Five patients were Caucasian (83%), and 1 was Black/African American (17%). Two patients had late stage GMF with M2 (CD163) predominance and the other three had early stage GMF with M1 (pSTAT1) predominance. Our study suggests that macrophage polarization present in GMF tends to be M1 in early stages and M2 in advanced stages. Additional studies are needed to further elucidate the microenvironment of macrophages present in GMF. Such findings may lead to prognostic and therapeutic advances in GMF.
Exploring cryo-electron microscopy with molecular dynamics
Vant, John , Sarkar, Daipayan , Nguyen, Jonathan , Baker, Alexander T. , Vermaas, Josh V. , Singharoy, Abhishek , Vant, John W , Vermaas, Josh , Singharoy, Abhishek , Baker, Alexander , Sarkar, Daipayan , Nguyen, Jonathan

Mayo Clinic

Biochemical Society Transactions | February 25, 2022 | Volume: 50 | Issue: 1 | Pages: 569-581

10.1042/bst20210485 | PMID 35212361 Get It

Single particle analysis cryo-electron microscopy (EM) and molecular dynamics (MD) have been complimentary methods since cryo-EM was first applied to the field of structural biology. The relationship started by biasing structural models to fit low-resolution cryo-EM maps of large macromolecular complexes not amenable to crystallization. The connection between cryo-EM and MD evolved as cryo-EM maps improved in resolution, allowing advanced sampling algorithms to simultaneously refine backbone and sidechains. Moving beyond a single static snapshot, modern inferencing approaches integrate cryo-EM and MD to generate structural ensembles from cryo-EM map data or directly from the particle images themselves. We summarize the recent history of MD innovations in the area of cryo-EM modeling. The merits for the myriad of MD based cryo-EM modeling methods are discussed, as well as, the discoveries that were made possible by the integration of molecular modeling with cryo-EM. Lastly, current challenges and potential opportunities are reviewed.
Long‐term outcome of immunologic autograft engineering
Porrata, Luis F. , Inwards, David J. , Ansell, Stephen M. , Micallef, Ivana N. , Johnston, Patrick B. , Paludo, Jonas , Villasboas, José C. , Paludo, Jonas , Markovic, Svetomir N.

Mayo Clinic

eJHaem | February 25, 2022 | Volume: 3 | Issue: 2 | Pages: 488-491

10.1002/jha2.404 | PMID 35846064 Get It

AbstractOur phase III trial reported that autograft‐absolute lymphocyte count (A‐ALC) improved survival post‐autologous peripheral blood hematopoietic stem cell transplantation (APBHSCT) for a short‐term follow‐up of 2 years. We evaluated retrospectively in our phase III trial patients that the A‐ALC still confers survival benefit with a longer follow‐up. With a median follow‐up of 127.6 months, patients infused with an A‐ALC ≥ 0.5 × 109 cells/kg experienced better overall survival (HR = 0.392, 95% confidence of interval [CI]: 0.224–0.687, p < 0.001) and progression‐free survival (HR = 0.413, 95% CI: 0.253–0.677), p < 0.0004). This study supports that A‐ALC provides long‐term survival benefit post APBHSCT.
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials
Fonseca, Adriana , Faure‐Conter, Cécile , Murray, Matthew J. , Fangusaro, Jason , Bailey, Shivani , Goldman, Stewart , Khatua, Soumen , Frappaz, Didier , Calaminus, Gabriele , Dhall, Girish , Nicholson, James C. , Bouffet, Eric , Bartels, Ute , Dhall, Girish , Bouffet, Éric , Bartels, Ute

Mayo Clinic

Neuro-Oncology | February 24, 2022 | Volume: 24 | Issue: 11 | Pages: 1950-1961

10.1093/neuonc/noac057 | PMID 35218656 Get It

Abstract Background Central Nervous System Non-Germinomatous Germ Cell Tumors (CNS-NGGCT) are rare but curable tumors. Due to their rarity, patients with treatment failures remain a poorly characterized group with unfavorable outcomes. In this study, we sought to characterize patients with treatment failures in a large, prospectively treated cohort. Methods European and North American clinical trials for patients with CNS-NGGCT (SIOP-GCT-96, SFOP-TGM-TC 90/92, COG-ACNS0122, and COG-ACNS1123) were pooled for analysis. Additionally, patients included and treated in the UK and France national registries under strict protocol guidelines were included as an independent, non-overlapping cohort. Results A total of 118 patients experienced a treatment failure. Twenty-four patients had progressive disease during therapy, and additional 11 patients were diagnosed with growing teratoma syndrome (GTS). Patients with GTS are significantly younger and present with local failures and negative tumor markers. Eighty-three individuals experienced disease relapses after treatment ended. Patients’ metastatic relapses presented significantly earlier than local relapses and were associated with tumor marker elevation (OR: 4.39; P = .026). In our analysis, focal or whole-ventricular radiation therapy was not associated with an increased risk of metastatic relapses. Conclusions Herein, we present the largest pooled dataset of prospectively treated patients with relapsed CNS-NGGCT. Our study identified younger age and negative tumor markers to be characteristic of GTS. Additionally, we elucidated that metastatic relapses occur earlier than local relapses are associated with elevated tumor markers and are not associated with the field of radiation therapy. These findings are of utmost importance for the planning of future clinical trials and the implementation of surveillance strategies in these patients.